A portion of amino acids 260-288 from the human protein was used as the immunogen for this CD80 antibody.
CD80, or activation antigen B7-1 (formerly referred to as B7) provides regulatory signals for T lymphocytes as a consequence of binding to the CD28 and CTLA4 ligands of T cells.
